SHARx Analyzes TrumpRx: Transparency on Drug Costs Doesn't Resolve Pricing and Access Gatekeeping
PR Newswire —
The launch of the Trump administration's TrumpRx drug platform is renewing scrutiny of prescription drug costs. Beyond sticker shock, the mechanisms behind drug pricing and access come down to the complexity of pharmacy benefit manager (PBM) systems that control coverage, rules, and...